Why the study?
What is the natural history and 5-year survival rate of central-type osteogenic sarcoma in the long bones of patients under 21 years of age?
Population
145 patients under the age of twenty-one years with central-type osteogenic sarcomas in the long bones.
Design
Cohort
Follow-up
5 years
Authors
Loading...
Provides a historical control benchmark for central osteogenic sarcoma in adolescents; leaves open the impact of modern therapies.
What is the natural history and 5-year survival rate of central-type osteogenic sarcoma in the long bones of patients under 21 years of age?
The 5-year survival rate for osteogenic sarcoma in patients under 21 was 17.4%, providing a historical control series for evaluating future treatments.
Marcove et al. (1970) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: